UK start-ups raised £439m in the week to 6 November, according to Startupmag's weekly tally, but four transactions worth a combined £347m accounted for roughly 79% of the money. One of those four, an £79.4m facility for NexGen Cloud, was debt rather than equity.
The figures show how concentrated British venture funding has become. A handful of large cheques in biotech, wealth management and AI infrastructure drove the headline number. Most of the remaining rounds were seed and Series A deals below £10m.
Biotech and healthtech took the largest share. Cambridge's T-Therapeutics raised a £100m Series B co-led by Advent Life Sciences and the British Business Bank. Oxford spinout Alethio Therapeutics closed an oversubscribed £67m Series A backed by Sofinnova Partners, RA Capital and Oxford Science Enterprises.
Including smaller rounds from OSSTEC and Bioliberty, the sector accounted for about £180m, or roughly 41% of the week's total.
Wealth and infrastructure
The second-largest deal was not a venture round. Hoxton Wealth, the London- and Dubai-based adviser to internationally mobile clients, agreed a strategic minority investment of about £100m from Aspirity Partners I. It is the company's first outside capital since it was founded in 2018, and founder Chris Ball keeps majority control. The valuation was not disclosed.
NexGen Cloud's £79.4m senior secured facility, led by USD.AI, will fund 216 Nvidia HGX B300 servers. The structure is secured against hardware and contracted revenue, which lets the GPU provider grow capacity without diluting its shareholders. On its own, the facility made up about 18% of the week's total.
The long tail
Further down the table, deal sizes fell quickly. FluoRok raised an oversubscribed £22.3m Series A to scale fluorochemical manufacturing without hydrogen fluoride. Supa's £21m package, which combined seed equity with a debt facility, will fund further acquisitions of block-management agents.
Other deals were much smaller. They included MMC's roughly £9m Series A in trading-infrastructure firm LO:TECH, and seed rounds for Ares Intelligence (£2.5m, led by Creandum and Lakestar) and Crediflow AI (£1.5m). Climate rounds came from Viridi (£2.2m), Luthmore (£4.5m) and Rookwood Operations (£800,000).
Manchester's Skiddle also took its first external investment in 25 years, a growth deal led by Soho Square Capital. Terms were not disclosed.
What it signals
The week fits a pattern seen through 2026: fewer deals, with capital concentrated in companies that have a clear clinical, regulatory or contracted-revenue milestone. Debt is also playing a bigger role. Asset-backed facilities such as NexGen's are being used to fund hardware that equity investors would once have paid for in full.
For founders below Series B, the numbers mean a smaller pool of capital. Once the four largest transactions are removed, the rest of the market raised about £92m across more than a dozen companies.
Original source: Startupmag — https://www.startupmag.co.uk/funding/uk-startup-funding-report-06-11-2026
